1Nieholson AG,Colby TV,du Bois RM,et al.The prognostic significance of the histologie pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenie fibrosing alveolitis[J].Am J Respire Cfit Care Med,2002,162(6):2213-2217.
2Hagiwara S,Ishii Y,Kitamura S.Aerosolize administration of N-Acetyl-cysteine allenuates lung fibrosis induced by bleomycin in mice[J1.Am J Respir Crit Care Med,2000,162(2):25-31.
4Marzec JM,Christie JD,Reddy SP,et al.Functional polymorphisms in the transcription factor NRF-2 in humans increase the risk of acute lung injury[J].FAS EBJ,2007,21 (9):2237-2246.
6Desaki M,Okazaki H,Sunazuka T,et al.Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells:possible role in the signaling pathway that regulates nuclear factor-kappaB activation[J].Antimierob Agents Chemother,2004,48 (5):1581 - 1585.
7Wang R,Ibarra SO,Verlins Ri L,et al.Abrogation of bleomycin induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor.Am J Physiol Lung Cell Mol Physiol,2000,279(6):143 - 151.
8Buchdunger E,O'Reilly T,Wood J.Pharmacology of imatinib(ST1571)[J].Eur J Cancer,2002,38 (Suppl5):S28 -36.
9O'Callaghan D,Gaine SP.Bosentan:a novel agent for the treatment of pulmonary arterial hypertension[J].Int J Clin Pract,2004,58(1):69-73.
10Crestani B,Dehoux M,Hayem G,et al.Differential role of neutrophils and alveolar macrophages in hepatocyte growth factor production in pulmonary fibrosis[J].Lab Invest,2002,82:1015-1022.
